Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1
For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1
For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1
Submitted by
admin
on April 12, 2017 - 6:09pm
Source:
TheStreet.com
News Tags:
biotech
ImmunoCellular Therapies
Lion Biotechnologies
Anavex Life Sciences
Galena Biopharma
CytRx
OncoSec
NeoStem
Headline:
For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1
Do Not Allow Advertisers to Use My Personal information
